This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Healthways Reports Earnings Of $0.15 Per Diluted Share For Third Quarter 2012

Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc. (NASDAQ: HWAY), today announced financial results for the third quarter ended September 30, 2012. Total revenues were $166.6 million for the quarter compared with $176.2 million for the third quarter of 2011. Net income for the third quarter of 2012 was $5.0 million, or $0.15 per diluted share, compared with $9.5 million, or $0.28 per diluted share, for the third quarter of 2011.

Leedle commented, “We are pleased by our third-quarter results. Our results exceeded our expectations as we benefited from earlier than expected recognition of performance-based fees, which helped to partially offset the impact of the continued wind-down of the Cigna contract. For the third quarter, the Cigna wind-down resulted in comparable-quarter and sequential-quarter declines in revenue from Cigna of $19 million and $5 million, respectively. Excluding the effect of this wind-down, revenues for the third quarter of 2012 increased 6% from the third quarter of 2011 (see pages 8 and 9 for a reconciliation of GAAP and non-GAAP measures).

COMPARISON OF COMPONENTS OF NET INCOME PER DILUTED SHARE

 
   

Three Months Ended

   

Nine Months Ended

September 30,

September 30,

2012

   

2011

2012

   

2011 (1)

Domestic $ 0.14 $ 0.31 $ 0.26 $ 0.66
International   0.01   (0.03 )   (0.04 )   (0.09 )
Net income per diluted share $ 0.15 $ 0.28   $ 0.22   $ 0.56  
 

(1) Figures may not add due to rounding.

 

Strong Business Development Momentum Drives New, Expanded and Extended Contracts

“We are also very pleased with our continued strong business development momentum during the second half of 2012,” Leedle noted. “The third quarter was one of our most successful contracting periods ever, with 30 signed contracts: 12 were with new customers, eight were expanded and extended, and 10 more were extended. Further, our business development momentum is continuing in the fourth quarter, with an additional eight contracts already executed and more signed contracts expected before year end.

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs